The Clorox Company (NYSE:CLX – Free Report) – Investment analysts at Zacks Research boosted their Q1 2026 earnings per share estimates for Clorox in a research note issued on Wednesday, November 13th. Zacks Research analyst R. Lohia now anticipates that the company will earn $1.75 per share for the quarter, up from their previous estimate of $1.41. The consensus estimate for Clorox’s current full-year earnings is $6.85 per share.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 earnings per share.
Get Our Latest Report on Clorox
Clorox Stock Performance
Clorox stock opened at $167.64 on Monday. The firm has a market capitalization of $20.75 billion, a P/E ratio of 58.41, a PEG ratio of 3.10 and a beta of 0.41. The stock has a fifty day moving average price of $162.45 and a 200 day moving average price of $147.52. Clorox has a 52 week low of $127.60 and a 52 week high of $169.09. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the company. Prospera Private Wealth LLC bought a new position in Clorox during the 3rd quarter worth approximately $27,000. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Innealta Capital LLC bought a new stake in shares of Clorox in the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC lifted its holdings in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the last quarter. Finally, Quarry LP lifted its holdings in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.
Insiders Place Their Bets
In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 11.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.57% of the stock is currently owned by company insiders.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 170.03%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.